- Home
- YMAB vs TLS Comparison
YMAB vs TLS Comparison
Compare YMAB & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- TLS
- Stock Information
- Founded
- YMAB 2015
- TLS 1969
- Country
- YMAB United States
- TLS United States
- Employees
- YMAB N/A
- TLS N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- TLS EDP Services
- Sector
- YMAB Health Care
- TLS Technology
- Exchange
- YMAB Nasdaq
- TLS Nasdaq
- Market Cap
- YMAB 270.5M
- TLS 233.1M
- IPO Year
- YMAB 2018
- TLS 2020
- Fundamental
- Price
- YMAB $5.72
- TLS $3.16
- Analyst Decision
- YMAB Strong Buy
- TLS Buy
- Analyst Count
- YMAB 10
- TLS 5
- Target Price
- YMAB $21.10
- TLS $4.50
- AVG Volume (30 Days)
- YMAB 542.6K
- TLS 315.3K
- Earning Date
- YMAB 03-04-2025
- TLS 03-14-2025
- Dividend Yield
- YMAB N/A
- TLS N/A
- EPS Growth
- YMAB N/A
- TLS N/A
- EPS
- YMAB N/A
- TLS N/A
- Revenue
- YMAB $84,553,000.00
- TLS $122,959,000.00
- Revenue This Year
- YMAB $6.41
- TLS N/A
- Revenue Next Year
- YMAB $18.15
- TLS $38.31
- P/E Ratio
- YMAB N/A
- TLS N/A
- Revenue Growth
- YMAB N/A
- TLS N/A
- 52 Week Low
- YMAB $5.60
- TLS $1.89
- 52 Week High
- YMAB $20.90
- TLS $5.03
- Technical
- Relative Strength Index (RSI)
- YMAB 35.08
- TLS 43.61
- Support Level
- YMAB $5.60
- TLS $3.45
- Resistance Level
- YMAB $6.57
- TLS $3.71
- Average True Range (ATR)
- YMAB 0.38
- TLS 0.20
- MACD
- YMAB 0.10
- TLS -0.00
- Stochastic Oscillator
- YMAB 11.43
- TLS 30.38
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.